Skip to content
MS
unreviewed

ATGL

0 reactions · 0 pathways

What it does, reaction by reaction

0 reactions

This enzyme appears only in the regulation table, with no catalysed step recorded.

What accelerates and inhibits it

Regulation is pathway-specific, so each context is listed separately

1 entries

Triacylglycerol Synthesis and Lipolysis

Accelerated by

CGI-58/ABHD5; phosphorylation-dependent perilipin remodeling

Inhibited by

G0S2; insulin-mediated suppression

Hormonal control

Catecholamines activate cAMP/PKA and mobilize ATGL coactivation; insulin suppresses lipolysis

Recent literature

Europe PMC · fetched just now · sorted by publication date

  1. 1
    Phloretin as a functional feed bioactive in livestock: Biological role, biosynthesis, and practical applications.

    Areb E, Zhu Q, Han L, Pan C, Li W, Lan X. · 2026-07-25

    open access unreviewed
  2. 2
  3. 3
    Pre-winter feeding high-fat diet with caffeic acid phenethyl ester attenuates weight loss and improves health and muscle quality in grass carp during overwintering.

    Li H, Tang L, Yuan X, Ren Z, Wei M, Tian Z, Xue R, Gao Z, Liu C, Ji H, He G, Sun J. · 2026-08-07

    open access unreviewed
  4. 4
    Triacylglycerol metabolism is a novel target to combat West Nile virus infection.

    Caridi F, Mingo-Casas P, Esteban A, Poderoso T, de Oya NJ, Calvo-Pinilla E, Zhang B, Priego EM, Pérez-Pérez M… · 2026-09-18

    open access unreviewed
  5. 5
  6. 6
    Targeting ROAM1 with UDP-GlcNAc nanosheets selective activates lysosomal AMPK to resolve metabolic dysfunction-associated steatotic liver disease.

    Zhu J, Sun T, Wei F, Wang D, Liu F, Chen D, Liu X, Wang C, Deng S, Yang Y, Xiong Y, Xiang H, Li J, Li S, Ma W… · 2026-07-12

    open access unreviewed
  7. 7
    Peptide-functionalized nanoemulsions with exendin-4 as a model ligand.

    Holler N, Gesslbauer B, Tam-Amersdorfer C, Letofsky-Papst I, Mayrhofer C, Andreae F, Zimmer A. · 2026-07-02

    open access unreviewed
  8. 8
  9. 9
    The role of protein palmitoylation in disease pathogenesis and therapeutic innovation.

    Lin X, Xing J, Jia K, Liu S, Liu Y, Gu Y, Guo K, Yi J. · 2026-05-29

    open access unreviewed
  10. 10
    A review of the sirtuins family: pivotal regulators and emerging therapeutic targets in renal fibrosis.

    Deng Q, Li C, Luo J, Yin M, Qian S, Li L. · 2026-05-14

    cited 1× open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.